Safety analysis of robotic right-hemicolectomy for right sided colon cancer

未提供0 个研究点目标入组 41 人开始时间: 2021年8月24日最近更新: 2024年1月18日

试验速览

暂无简介。

•Patients over 20 years old age
•Histologically, diagnosed with colon cancer
•Preoperative diagnosis of curative primary resection
•Main tumor site is cecum (C), ascending colon (A) or right-sided transverse colon (T) and right-hemicolectomy with D2 or higher lymph node dissection is pre-planned
•Clinical stage I to IIIC (T1-4b, N0-2b, M0: TNM Classification) has been diagnosed
•Patients who are diagnosed out of the endoscopic resection
•Patients with tumor maximum diameter of 8 cm or less
•Patients who do not recognize multiple lesions that require two or more anastomosis places
•Patients with ECOG Performance Status (PS) score of 0 to 1
•Patients who have the judgment to fully understand the research content.
•Patients with written informed consent to participate in this study.

•Patients with chemotherapy (systemic anti-cancer drug treatment) and a history of radiation therapy, including treatment for other cancer species.
•Patients who have a history of open surgery
•Patients who have a history of laparoscopic stomach resection or colectomy
•Patients with the latest check values within 14 days before registration meet the following
•Leukocyte <3000 / mm 3,
•Platelet <75,000 / mm 3,
•Hemoglobin <7 G / DL,
•AST> 100 IU / L,
•ALT> 100 IU / L,
•Serum Cr> 1.5 mg / dl.
•Other patients who are judged to be unsuitable as a subject by the doctor's judgment.

Postoperative complications within 30 days after surgery

发起方

未提供